< Back to situations

[ORGANIZATION]

Defilade Capital Management L.P.

Featured in 3 tracked stories · first seen

Situations

[ACTIVE] [BUSINESS]

Institutional investment in Denali Therapeutics

2 clusters · 2 sources · last updated

Latest: Institutional investors adjust holdings in Denali Therapeutics and Delta Air Lines

Institutional investors have shown increased interest in Denali Therapeutics Inc. through significant stake acquisitions. Defilade Capital Management L.P. more than doubled its position in the first quarter, holding appr

[QUIET] [BUSINESS] [US]

Elanco Animal Health corporate activity

2 clusters · 5 sources · last updated

Latest: Elanco Animal Health lifts earnings outlook on surge in tick‑related demand

In early August 2026, institutional investors increased their holdings in Elanco Animal Health, with Defilade Capital Management boosting its stake by 132% to about 0.19% of the company. Several other firms also raised t

[QUIET] [BUSINESS] [US]

Institutional investors adjust US stock stakes

2 clusters · 2 sources · last updated

Latest: Institutional Investors Increase Stakes in Oric Pharma and Universal Health Services

Late July and early August 2026 saw a series of portfolio adjustments by large institutional owners across U.S. publicly traded companies. Edgestream Partners increased its holding in Graham Holdings to about 0.24%, whil